This week’s XBI pullback is healthy. Biotech stocks cannot go up every day. The sector’s recovery off the April lows has been ...

Living with a neurologic illness is an exercise in ambiguity,” Shaheen Lakhan writes in a powerful essay about the blurry ...

How much alcohol is “too much,” in terms of cancer risk? Identifying causes helps us make decisions — both as individuals and ...

But more quietly, the company is still moving forward with its pipeline, including cancer and rare disease therapeutics. The ...

CVS Caremark, the largest PBM in the U.S., tells activists Gilead needs to lower the price of its new HIV drug to get on ...

Moderna said its experimental vaccine for cytomegalovirus failed in a key trial, a significant setback for a company already ...

D.C.-area folks: Flying V at Silver Spring Black Box Theatre is currently putting on “Doctor Moloch ,” a play about a humanoid AI doctor who has to learn about empathy. I beg of you, please see this ...

More than 420 anti-science bills attacking longstanding public health protections have been introduced in statehouses across ...

The leading professional organization for European oncologists has rolled out its first set of guidance on how its members ...

Some companies are pitching a new model for employers to help their workers pay for medications, but without using insurance.

The Trump administration is preparing a new probe into drug-pricing practices among U.S. trading partners, laying the ground ...

Arcturus Therapeutics reported interim results from a mid-stage study of an mRNA-based treatment for cystic fibrosis that ...